See also this year's filing and all EDGAR filings for this company.
PDF Report 0001799191_2022_Oncology_Institute_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.2589042568439157, 'aggregate_val': 248190000, 'exp_sum': 334896000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 83365000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 248861000, 'DepreciationDepletionAndAmortization': 3341000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': -671000}} |
Graph
Absolute values for 0001799191, Oncology Institute Inc.
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 44,871,000 |
| 1 | AssetsNonCurrent | 320,000 |
| 2 | AssetsCurrent | 154,056,000 |
| 3 | PropertyPlantAndEquipment | 4,192,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 6,900,000 |
| 6 | LiabilitiesCurrent | 30,169,000 |
| 7 | remainder_Liabilities | 62,211,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 83,365,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 248,861,000 |
| 13 | DepreciationDepletionAndAmortization | 3,341,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -87,377,000 |
| 17 | remainder_Revenues | 203,003,000 |
| 18 | remainder_NetIncome | 34,260,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 203,439,000 |
| 1 | Liabilities | 99,280,000 |
| 2 | Expenses | 248,190,000 |
| 3 | Revenues | 203,003,000 |
| 4 | StockholdersEquity | 104,159,000 |
| 5 | NetIncome | -10,927,000 |
| 6 | ComprehensiveNetIncome | -10,927,000 |
| 7 | BaseVar | 474,185,745 |
| 8 | EconomicCapitalRatio | 1.07 |
Edgar->Model Mapping
Feature Distribution
Change over Time
